Cargando…

Hydroxychloroquine-related psychiatric disorders in COVID-19 patients

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645021/
http://dx.doi.org/10.1007/s40278-020-85085-y
_version_ 1783606577896357888
collection PubMed
description
format Online
Article
Text
id pubmed-7645021
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-76450212020-11-06 Hydroxychloroquine-related psychiatric disorders in COVID-19 patients Reactions Weekly Clinical Study Springer International Publishing 2020-10-31 2020 /pmc/articles/PMC7645021/ http://dx.doi.org/10.1007/s40278-020-85085-y Text en © Springer International Publishing AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Clinical Study
Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title_full Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title_fullStr Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title_full_unstemmed Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title_short Hydroxychloroquine-related psychiatric disorders in COVID-19 patients
title_sort hydroxychloroquine-related psychiatric disorders in covid-19 patients
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7645021/
http://dx.doi.org/10.1007/s40278-020-85085-y